Ant Group Brings Alipay+ to the Philippines with Three New Mobile Wallets, AlipayHK, Kakao Pay and Touch ‘n Go eWallet
Ant Group, the operator of Alipay+, the global cross-border digital payments and marketing solution, today announced that a total of four mobile wallets are now accepted in the Philippines. These include AlipayHK (Hong Kong SAR), Kakao Pay (South Korea), Touch ‘n Go eWallet (Malaysia) and Alipay (Chinese mainland), which has been accepted by Filipino merchants since 2017. This enables travellers from these regions to enjoy a cashless experience, using just their home mobile wallets to make payment, improving the travel experience as digital payment options like mobile wallets become the norm for day-to-day transactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230904840228/en/
Mactan-Cebu International Airport, which saw 219% increase in passengers in the 1H of 2023, have integrated Alipay+ across 90% of its merchants (Photo: Business Wire)
The acceptance of three new mobile wallets, via Alipay+, comes as travellers return to the Philippines. According to the Department of Tourism (DOT), more than 3 million tourists have visited the Philippines from January 1 to July 19, 2023, reflecting continued robust recovery. The DOT also shared that inbound tourism receipts from January 1 to June 30, 2023, are more than 500% higher than the same period last year1. South Koreans top the list of international visitors to the Philippines, while Malaysia ranks in the top 102.
Alipay+ is currently accepted by merchants in Manila and Cebu, the top two most visited cities in the Philippines pre-pandemic in 20193. In the first half of 2023, Mactan-Cebu International Airport saw a 219% increase in passengers compared to the same period last year. In order to cater to the new expectations of digital-first travellers, the airport has integrated Alipay+ across 90% of its merchants, ensuring that tourists can enjoy a digitally-enhanced cashless experience from the moment they arrive in Cebu.
Athanasios Titonis, Aboitiz InfraCapital Chief Executive Officer assigned to MCIA, said: “At MCIA, we have always placed utmost importance on providing convenience and ease of travel through seamless processes and world-class services and amenities. The integration of Alipay+ gives our passengers that exceptional convenience and more payment options when they travel through MCIA.”
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines with over 11 million passengers annually, making it the second busiest airport in the country. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. To date, MCIA is the first and only airport in the Philippines to receive the Airport Customer Experience (ACX) accreditation from the Airports Council International.
Commenting on this new development, Dr. Cherry Huang, General Manager of Alipay+ Offline Merchant Services at Ant Group, said: “Philippines and its many islands, such as Cebu, have long been a favourite destination for Asian travellers and we look forward to working with our local partners to enhance their travel experience. We believe that digital adoption and solutions will shape travellers’ expectations, particularly in the way the engage travel-related businesses, from airports and hospitality to F&B and retail stores. Our focus now is to work with more partners to onboard more merchants with Alipay+ across the Philippines, particularly local small businesses, and promote digital travel and travel recovery.”
Introduced by Ant Group in 2020, Alipay+ aims to enable local businesses, especially small and medium-sized businesses, to process a wide range of mobile payment methods and reach more than 1.4 billion regional and global consumers, through one-time integration and simple technical adaption. In addition to the Philippines, Alipay+ is also widely accepted in destinations including the Chinese mainland, Macao SAR, Singapore, Thailand, Japan and South Korea among others.
About Mactan-Cebu International Airport
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines. It serves over 11 million passengers annually, making it the second busiest airline hub in the country. MCIA is operated by a Filipino-led private consortium between Aboitiz InfraCapital (AIC), GMR Group of India, and Megawide Construction Corporation (MCC), under a concession agreement with the Philippine Government. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. MCIA is accredited for the Airport Customer Experience (ACX) and the Airport Health Accreditation (AHA) by the Airports Council International.
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
Ant Group is the owner and operator of Alipay, the leading digital payment platform in China serving hundreds of millions of users, and connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services such as food delivery, transport, entertainment, and healthcare.
Ant Group has further introduced Alipay+, which provides global cross-border mobile payments and marketing solutions that connect merchant partners, especially small and medium-sized businesses, with mobile payments and other payment methods, for them to better serve their users and customers from all over the world.
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
1 Manila Bulletin (19 July 2023): PH int’l tourists breach 3M mark, revenues hit P212B
2 Department of Tourism: Tourism demand statistics 2023
3 Department of Tourism: Visitor arrivals: January – December 2019
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230904840228/en/
Contact information
Scott Lai
scott.lai@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Positive Phase 3 Results Support ZIIHERA ® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA ® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma17.11.2025 13:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with or without PD-1 inhibitor TEVIMBRA® (tislelizumab), as first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA), including cancers of the stomach, gastroesophageal junction, and esophagus. Both ZIIHERA plus TEVIMBRA and chemotherapy and ZIIHERA plus chemotherapy demonstrated clinically meaningful and highly statistically significant improvements in progression-free survival (PFS) compared to the control arm, trastuzumab plus chemotherapy. ZIIHERA plus TEVIMBRA and chemotherapy also demonstrated clinically meaningful and statistically significant improvements in overall survival (OS), and ZIIHERA plus chemotherapy demonstrated a clinically meaningful eff
Global Winners of the 2025–2026 World Branding Awards Announced at First-Ever Japan Ceremony17.11.2025 12:43:00 EET | Press release
Now in its 20th edition, the World Branding Awards continues to spotlight the world’s most impactful and trusted brands. This year, over 1,092 brands from 66 countries were nominated as “Brand of the Year”, with less than 100 declared Winners across Global, Regional, and National tiers. The World Branding Awards Ceremony stepped outside London for the first time, bringing its global presence to the Osaka City Museum of Fine Arts. The 2025–2026 edition welcomed over 80 international guests and was presented by the acclaimed Allie Sakakibara. The evening was further elevated by a keynote presentation from Miho Noguchi, who shared insights on building emotional resonance through immersive brand experiences. Global Tier winners celebrated their outstanding branding excellence across various industries, including IKEA (Sweden), Lurpak (Denmark), Marriott International (United Kingdom), Nike (USA), Sennheiser (Germany), and Yakult (Japan). These brands consistently demonstrated strength, inf
Henlius and Organon Announce US FDA Approval of POHERDY ® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US17.11.2025 12:30:00 EET | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product.1 POHERDY is the first and only approved pertuzumab biosimilar in the US, representing an important milestone in expanding access to quality and potentially more affordable biologic therapies for patients with certain HER2-positive breast cancers.2 "Expanding access to treatments for diseases that disproportionately impact women, including breast cancer, the most common cancer among women in the US excluding skin cancer, is at the core of our mission,” said Jon Martin, US Commercial Lead, Biosimilars and Established Brands at Organon.3 “Not only is POHERDY the first approved biosimilar to PERJETA in the US, but its approval also builds
WEX ® Unlocks Access to 20,000+ Tesla Superchargers Across Europe17.11.2025 12:15:00 EET | Press release
WEX® (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced integration with the Tesla Supercharger network, adding over 20,000 fast-charging points across 1,500+ locations to its platform. The move significantly expands charging options for WEX’s customers, particularly in areas where high-power charging has been limited or expensive. By bringing Tesla Superchargers into their ecosystem, WEX gives drivers access to competitively priced fast charging with speeds up to 250 kW, increasing availability of high-power charging stations by 10%. WEX customers already use the EV Driver by WEX app to charge at over 1 million charging points throughout Europe. Now, they can access Tesla Superchargers with the same seamless experience: comparing real-time pricing across all networks, planning optimal routes, tracking sessions, and managing payments in one unified platform - regardless of the charging network they choose. “Providing access to
Global Cement Industry Reports 25% CO 2 Intensity Reduction and Calls for Urgent Government Action to Accelerate Net Zero Mission17.11.2025 12:00:00 EET | Press release
The extensive decarbonisation work being carried out by the global cement and concrete industry to cut CO₂ emissions is set out in a new global report launched at COP30 in Belem, Brazil. The report details latest industry data showing that the sector is making progress, and also emphasises the need for urgent global government input to help accelerate action. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117920702/en/ GCCA Cement and Concrete Industry Net Zero Action and Progress Report The report finds that the industry has reduced the CO₂ intensity of cementitious products by 25% across the globe since 1990, and also sets out a series of policy recommendations that can pave the way for faster reductions. Dominik von Achten GCCA President and Chairman of the Managing Board of Heidelberg Materials said: "Our industry is collaborating and innovating across every aspect of our manufacturing – finding new ways to work and d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom